Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Pharmacogenetics in Efavirenz and Nevirapine Pharmacokinetics, Efficacy and Safety in Mother-infant Pairs During Pregnancy and Lactation

NCT02269462 is registered in ClinicalTrials.gov with Adeniyi Olagunju as lead sponsor.

NCT NCT02269462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02269462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Pharmacogenetics in Efavirenz and Nevirapine Pharmacokinetics, Efficacy and Safety in Mother-infant Pairs During Pregnancy and Lactation
Lead sponsor
Adeniyi Olagunju
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
November 30, 2013
Enrollment
460 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breastfeeding, hiv, pregnancy